PET-CT模拟定位与CT在头颈癌放疗中的比较及其对甲状腺的潜在影响
这项前瞻性比较研究将头颈癌患者按模拟定位方式分为PET-CT组和CT组,于放疗前后采集血样,用ECLIA检测TSH、FT3、FT4。结果显示PET-CT使GTVp勾画准确性提高71.8%;放疗后FT3、FT4显著下降,TSH仅轻微、非显著下降,II/III期更明显。
要点
- PET-CT模拟定位较CT使GTVp勾画准确性提高71.8%。
- 放疗后FT3、FT4显著下降,TSH仅轻微且非显著下降。
- PET-CT组FT4受影响略大,需监测甲状腺功能。
核心结论
- PET-CT模拟定位的GTVp勾画准确性优于CT,可改善头颈癌放疗计划。
- 放疗后血清FT3和FT4显著下降,TSH仅轻微、非显著下降,II/III期更明显。
- PET-CT组FT4受影响略大,提示需监测甲状腺功能并常规内分泌随访。
研究设计与样本
- 前瞻性比较研究,头颈癌患者按模拟定位方法分为PET-CT组与CT组。
- 每例患者放疗前后各采集两份5 mL新鲜血样。
- TSH、FT3、FT4采用电化学发光免疫分析(ECLIA)检测。
主要发现
- PET-CT模拟定位使GTVp勾画准确性较CT提高71.8%。
- 放疗后TSH水平呈轻微下降变化,FT3和FT4显著下降。
- FT3和FT4下降在II期和III期更明显。
- 最常见肿瘤部位为喉部,PET-CT组占60%,CT组占75%,其后为舌、鼻咽和腮腺。
- FT4在PET-CT模拟组受影响略大。
关键数值与推荐
- PET-CT模拟定位较CT使GTVp勾画准确性提高71.8%。
- 最常见肿瘤部位:喉部PET-CT组60%、CT组75%。
- 每份血样5 mL,放疗前后各采两份。
临床怎么用
- 头颈癌放疗计划可考虑整合PET-CT模拟定位以改善GTVp勾画。
- 放疗后应常规监测甲状腺功能,关注FT3、FT4变化,尤其II/III期患者。
局限性
- 原文摘要未报告样本量、随访时长及统计P值等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiotherapy (RT) plays a key role in multidisciplinary treatment of Head and neck cancers (HNCs). Over the past two decades, advances have improved RT's tumor control and toxicity profiles. Precise delineation of gross tumor volume and organs at risk using CT and PET-CT is crucial for safe and effective RT. Additionally, RT increases the risk of thyroid dysfunction, especially hypothyroidism. AIM: The present study compared PET-CT simulation and CT-alone planning in head and neck cancer (HNC) treatment, emphasizing their effects on thyroid gland function. METHODS: The patients were divided into two groups according to the simulation method (PET-CT or CT), two fresh blood samples (5 mL/ sample) were collected from each patient, before and after radiotherapy. TSH, FT3, and FT4 (Thyroid biomarkers) were assessed by electrochemiluminescent immunoassay (ECLIA). RESULTS: PET-CT simulation demonstrated a significant improvement in GTVp delineation accuracy by 71.8% compared with CT. After radiotherapy, TSH levels show minor decline changes, whereas FT3 and FT4 levels declined significantly, with greater declines observed in stages II and III. The most common tumor site was the larynx (60% in PET-CT, 75% in CT), followed by the tongue, nasopharynx, and parotid gland. CONCLUSION: PET-CT simulation offered superior GTVp delineation accuracy over CT, improving HNCs radiotherapy planning. Immediately after RT, radiotherapy caused significant declines in serum FT3 and FT4 levels, with only a minor, non-significant TSH declining, particularly in stage II/III disease. Notably FT4 is little more affected in PET-CT simulation patient group, highlighting the need for thyroid function monitoring. These results advocate PET-CT integration in planning and routine endocrine monitoring for treatment complications.
引用
- Nakhla SF, Abokasem YA, Elmansy H, et al. Comparative study between PET-CT simulation and CT for head and neck cancer treatment and their potential effect on the thyroid gland: a prospective comparative study. Radiat Oncol. 2026. PMID: 42144650. doi:10.1186/s13014-026-02840-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。